Wall Street Experts
ver. ZuMIgo(08/25)
Mabwell (Shanghai) Bioscience Co., Ltd.
Rachunek Zysków i Strat
Przychody TTM (mln): 167
EBIT TTM (mln): -1 051
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
| Rok finansowy |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
5 |
37 |
29 |
5 |
16 |
28 |
128 |
200 |
| Przychód Δ r/r |
0.0% |
712.1% |
-21.3% |
-82.0% |
206.0% |
70.9% |
360.5% |
56.5% |
| Marża brutto |
63.4% |
29.5% |
39.0% |
34.7% |
81.0% |
99.7% |
98.9% |
85.5% |
| EBIT (mln) |
-106 |
-237 |
-929 |
-657 |
-776 |
-991 |
-1,053 |
-1,043 |
| EBIT Δ r/r |
0.0% |
122.8% |
292.1% |
-29.3% |
18.1% |
27.8% |
6.2% |
-0.9% |
| EBIT (%) |
-2309.4% |
-633.7% |
-3155.7% |
-12386.0% |
-4781.1% |
-3575.4% |
-824.5% |
-522.3% |
| Koszty finansowe (mln) |
0 |
1 |
0 |
1 |
6 |
10 |
13 |
58 |
| EBITDA (mln) |
-91 |
-106 |
-886 |
-584 |
-688 |
-856 |
-927 |
-836 |
| EBITDA(%) |
-1970.0% |
-283.1% |
-3011.1% |
-11007.4% |
-4242.0% |
-3088.3% |
-725.9% |
-418.6% |
| Podatek (mln) |
-4 |
1 |
-1 |
3 |
1 |
-1 |
4 |
-1 |
| Zysk Netto (mln) |
-103 |
-225 |
-928 |
-646 |
-774 |
-957 |
-1,053 |
-1,044 |
| Zysk netto Δ r/r |
0.0% |
119.3% |
312.1% |
-30.4% |
19.7% |
23.8% |
10.0% |
-0.9% |
| Zysk netto (%) |
-2231.9% |
-602.6% |
-3154.5% |
-12186.4% |
-4767.0% |
-3453.0% |
-824.9% |
-522.5% |
| EPS |
-0.36 |
-0.79 |
-2.32 |
-1.62 |
-1.94 |
-2.4 |
-2.64 |
-2.61 |
| EPS (rozwodnione) |
-0.36 |
-0.79 |
-2.32 |
-1.62 |
-1.94 |
-2.4 |
-2.64 |
-2.61 |
| Ilośc akcji (mln) |
284 |
284 |
400 |
400 |
400 |
400 |
399 |
400 |
| Ważona ilośc akcji (mln) |
284 |
284 |
400 |
400 |
400 |
400 |
399 |
400 |
| Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |